Can a new shoulder implant restore arm function where others fail?
NCT ID NCT07764614
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This study is following people who receive a Tornier Perform™ Reversed MonoPost shoulder replacement to see how well it works and how safe it is. The implant is designed for patients with severe shoulder damage, such as from arthritis, fractures, or failed previous surgeries. Researchers will measure changes in shoulder function and pain over time. The goal is to confirm the device's real-world performance in a larger group of patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tornier Perform™ Reversed MonoPost shoulder replacement system
- What this could lead to
- If successful, this could confirm the device as a reliable option for improving shoulder function and reducing pain in people with severe shoulder damage.
- What could go wrong
- This is an observational follow-up study, not a randomized trial, so results may be influenced by patient selection. As with any shoulder replacement, risks include implant loosening, infection, or limited improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORRECTION OF FUNCTIONAL DEFORMITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which knee implant moves best? trial puts three designs to the test
- New knee device tracked in 757-Patient study
- Shoulder device under 10-Year watch
- New RA drug JADE201 enters first human safety trial
- Knee pain relief without surgery? collagen injection shows promise
- Knee cartilage repair: new cell therapy shows promise in small study